Details of the Drug Combinations

General Information of This Drug (ID: DM0QJDC)

Drug Name

Lixisenatide DM0QJDC

Synonyms

Lyxumia (TN)

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lixisenatide + Insulin-glargine	DCUI33J	Insulin-glargine	Type-2 diabetes	[2]
------------------------------------------------------------------------------------

References

1	2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
2	Clinical pipeline report, company report or official report of Sanofi.